Trial Profile
Long Term Treatment With Galantamine In Dementia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Feb 2011
Price :
$35
*
At a glance
- Drugs Galantamine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 19 Oct 2007 Status changed from in progress to completed.
- 16 Nov 2005 New trial record.